7-Bromo-2,3-dihydrobenzo[b][1,4]oxazepin-4(5H)-one, 98%, 1g

3-Chloro-N-[(piperidin-4-yl)methyl]pyridin-4-amine dihydrochloride, 1g

1H-Indazole-6-carboxylic acid, 5-chloro-, methyl ester, 97%, 250mg

1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-N-methylmethanamine hydrochloride, 95+%, 5g

2,2'-((1,2-Phenylenebis(azanylylidene))bis(methanylylidene))diphenol, 95.0%, 5g

7-Chloropyrazolo[1,5-a]pyrimidine, 95.0%, 100mg

2',7'-Dichlorodihydrofluorescein Diacetate>97.0%(HPLC)(T)100mg

Boc-D-Lys-OH, 98%, 1g

(1r)-1-(4-Phenylphenyl)ethan-1-amine hydrochloride, 98%, 250mg

Fasiglifam, 98.94%, 5mg

6-amino-2-(4-methylpiperazin-1-yl)pyrimidin-4(3H)-one, 250mg

1-(2-Chloropyrimidin-4-yl)-3-methyl-1H-pyrazole-4-carbaldehyde, 95.0%, 100mg

5-Bromo-2-methyl-1,3-dinitrobenzene, 95.0%, 1g